ArticleAdvanced pharmaceutical bulletin2025

Synergistic Enhancement of Osimertinib Efficacy in Non-small Cell Lung Cancer Cells Through Epigallocatechin-3-Gallate: Mechanistic Insights Into YAP/TEAD/CTGF Axis Inhibition.

Ashwini Somayaji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.